Consolidated Balance Sheets - USD ($) shares in Millions, $ in Millions		Dec. 31, 2024	Jun. 30, 2024
Current assets:
Cash and cash equivalents		$ 2,216.4	$ 2,913.4
Accounts receivable, net of allowance for doubtful accounts of $50.3 and $52.2, respectively		3,503.5	3,428.2
Other current assets		1,126.8	1,204.8
Total current assets before funds held for clients		6,846.7	7,546.4
Funds held for clients		47,407.7	37,996.1
Total current assets		54,254.4	45,542.5
Long-term receivables, net of allowance for doubtful accounts of $0.2 and $0.1, respectively		5.9	7.3
Property, plant and equipment, net		682.2	685.6
Operating lease right-of-use asset		342.9	370.6
Deferred contract costs		2,936.4	2,965.0
Other assets		951.9	1,102.1
Goodwill		3,183.9	2,353.6
Intangible assets, net		1,739.1	1,336.0
Total assets		64,096.7	54,362.7
Current liabilities:
Accounts payable		186.4	100.6
Accrued expenses and other current liabilities		3,088.7	3,349.0
Accrued payroll and payroll-related expenses		682.6	958.7
Dividends payable		621.6	566.4
Short-term deferred revenues		236.7	199.8
Obligations under reverse repurchase agreements	[1]	0.0	385.4
Short-term debt		1,000.5	1.1
Income taxes payable		4.4	15.1
Total current liabilities before client funds obligations		5,820.9	5,576.1
Client funds obligations		48,482.2	39,503.9
Total current liabilities		54,303.1	45,080.0
Long-term debt		2,982.0	2,991.3
Operating lease liabilities		300.3	328.6
Other liabilities		999.3	990.8
Deferred income taxes		90.8	64.3
Long-term deferred revenues		343.1	360.1
Total liabilities		59,018.6	49,815.1
Commitments and contingencies (Note 14)
Stockholders' equity:
Preferred stock, $1.00 par value: authorized, 0.3 shares; issued, none		0.0	0.0
Common stock, $0.10 par value: authorized, 1,000.0 shares; issued, 638.7 shares at December 31, 2024 and June 30, 2024; outstanding, 406.9 and 408.1 shares at December 31, 2024 and June 30, 2024, respectively		63.9	63.9
Capital in excess of par value		2,619.6	2,406.9
Retained earnings		24,335.6	23,622.2
Treasury stock - at cost: 231.8 and 230.6 shares at December 31, 2024 and June 30, 2024, respectively		(20,412.3)	(19,737.1)
Accumulated other comprehensive (loss)/ income		(1,528.7)	(1,808.3)
Total stockholders’ equity		5,078.1	4,547.6
Total liabilities and stockholders’ equity		$ 64,096.7	$ 54,362.7
Common stock, shares issued (in shares)		638.7	638.7

[1] As of June 30, 2024, $384.0 million of short-term marketable securities and $1.4 million of cash and cash equivalents have been pledged as collateral under the Company's reverse repurchase agreements (see Note 10).